Cytokinetics eps
WebCytokinetics is headquartered in South San Francisco, California, the US. Headquarters United States of America Address ., 280 East Grand Avenue, South San Francisco, California, 94080 Website cytokinetics.com Telephone 1 650 6243000 No of Employees 253 Industry Pharmaceuticals and Healthcare Ticker Symbol & Exchange CYTK (NASD) WebFeb 24, 2024 · Cytokinetics press release (CYTK): Q4 GAAP EPS of -$0.36 beats by $0.51.Revenue of $55.6M (+727.4% Y/Y) beats by $50.04M.Cash, cash equivalents and …
Cytokinetics eps
Did you know?
WebApr 10, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised. As a leader in muscle biology and the mechanics of … WebApr 13, 2024 · During the same quarter in the previous year, the firm posted ($0.36) EPS. Research analysts predict that Cytokinetics, Incorporated will post -4.4 earnings per share for the current fiscal year. Insiders Place Their Bets. In other Cytokinetics news, CEO Robert I. Blum sold 12,500 shares of the company’s stock in a transaction on Tuesday ...
WebFeb 25, 2024 · Cytokinetics (NASDAQ:CYTK): Q4 GAAP EPS of -$0.62 misses by $0.13.Revenue of $6.72M (+29.0% Y/Y) misses by $13.17M.Press Release … WebFlu-like symptoms (chills, fever, headache, fatigue, loss of appetite, nausea, vomiting) Low white blood cell counts (which increase the risk of infection) Skin rashes. …
WebApr 10, 2024 · The company is expected to report EPS of $2.50, down 6.37% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $23.56 billion, up 0.59% from ... WebFeb 24, 2024 · Cytokinetics press release (NASDAQ: CYTK): Q4 GAAP EPS of -$0.36 beats by $0.51. Revenue of $55.6M (+727.4% Y/Y) beats by $50.04M. Cash, cash equivalents and investments totaled $623.7 million...
WebMar 1, 2024 · Cytokinetics press release ( NASDAQ: CYTK ): Q4 GAAP EPS of -$1.45 misses by $0.24. Revenue of $1.96M (-96.5% Y/Y) misses by $4.5M. Now Read: Cytokinetics: Temper Your Expectations Of...
WebDec 31, 2024 · Analysts estimate that Cytokinetics will report an earnings per share (EPS) of $-1.21. Cytokinetics bulls will hope to hear the company announce they've not only beaten that estimate, but... inappropriate shift in verb tenseWebApr 10, 2024 · Cytokinetics (CYTK) Dips 20% so Far in 2024 on Setbacks Zacks Equity Research April 10, 2024 NVO Quick Quote CYTK Quick Quote Trades from $ 1 It has … incheck instascreenWebSOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on March 31, 2024 it granted stock options to purchase an aggregate of 57,600 shares of common stock to 4 new employees, whose employment commenced in March 2024, as a material inducement to their … inappropriate shirt at disneyWebOct 14, 2024 · Cytokinetics is a member of our Medical group, which includes 1189 different companies and currently sits at #3 in the Zacks Sector Rank. ... The consensus estimate for Humana's current year EPS ... incheck formulierincheck jobsWebApr 12, 2024 · Cytokinetics, Incorporated has a 1 year low of $32.96 and a 1 year high of $55.80. Cytokinetics ( NASDAQ:CYTK – Get Rating) last posted its earnings results on Wednesday, March 1st. The... inappropriate shifts in verb voice and moodWebCytokinetics, Incorporated CYTK: Raising target price to $38.00 CYTOKINETICS INC has an Investment Rating of HOLD; a target price of $38.000000; an Industry Subrating of … inappropriate shirts at disney